与药物相关的缺血性中风的危险因素:对FDA不良事件报告系统 (FAERS) 的分析
Weili Cao1, Bo Zhu2, Xiaotao Jia1
1Xi'an Central Hospital Affiliated to Xi'an Jiaotong University, No. 161 Xiwu Road, Xincheng District, China.
概括
这项研究使用现实世界的数据确定了66种与缺血性中风 (IS) 相关的药物. 关键的风险因素包括某些抗新生素和抗凝剂,突出显示了有针对性的药物监测的必要性.
科学领域:
- 药物监督和药物安全研究.
- 在临床药理学中生成真实世界的证据.
背景情况:
- 缺血性中风 (IS) 是一个主要的全球健康问题,具有显著的发病率和死亡率.
- 虽然已知一些药物会导致IS,但所有药物类别中药物诱导的IS的全面现实数据有限.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据库系统地分析药物与缺血性中风的关联.
- 确定导致IS的特定药理风险因素.
- 探索药物诱导IS发作的时间模式.
主要方法:
- 一个回顾性药监测研究,利用FAERS数据从2004年第一季度到2025年第一季度.
- 通过监管活动医学词典 (MedDRA) 识别IS病例首选术语.
- 使用ROR,PRR,BCPNN和MGPS算法进行不成比例分析,然后进行LASSO和后勤回归来独立识别风险因素.
主要成果:
- 分析了59,869份与毒品相关的IS报告,在22个类别中确定了66种重要药物.
- 抗新生素,抗凝固剂和抗血小板药物是最经常涉及的.
- 证实了64个独立的风险因素,包括特定的药物,如安德克萨内特阿尔法和罗菲科西布. 发病时间的中位数为77天.
结论:
- 本研究提供了基于真实世界的数据对药物-IS关联的全面描述.
- 确定了IS的多个强烈和独立的药理学风险信号.
- 这些发现支持明智的临床决策,并加强针对药物诱导IS的向药监策略.
相关概念视频
01:24Drug Toxicity: Risk factors
95
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
95
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:21Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
1.2K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.2K
01:29Therapeutic Drug Monitoring: Affecting Factors
313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313